Table 3.
Seizure characteristics in participants treated with early sirolimus during infancy.
Subject ID | 001 | 002 | 003 | 004 | 005 |
---|---|---|---|---|---|
| |||||
Seizure efficacy data | |||||
Age at 1st seizure (days) | -- | 319 | 592 | -- | 88 |
Duration of sirolimus treatment prior to 1st seizure (days) | -- | 178 | 511 | -- | 26 |
Lifetime total # of seizures prior to 12 months of age | 0 | 11 | 0 | 0 | 18 |
Lifetime total # of seizures prior to 24 months of age | 0 | 11 | 215 | 0 | 19 |
Monthly total # of seizures at 24-month visit (# of seizures in the previous 4 weeks) | 0 | 0 | 0 | 0 | 0 |
Seizure types developed by 24 months of age | -- | Infantile spasms only | Focal seizures only | -- | Infantile spasms and focal seizures |